Acerinox (ACX) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
19 Nov, 2025Opening remarks and agenda
Meeting held both in-person and online, with live broadcast and recording available for one month.
Legal and statutory requirements for valid constitution were verified, with sufficient quorum present and represented.
All directors were present; meeting notice published in official channels.
Agenda was extensive and taken as read; all documentation made available to shareholders in advance.
Financial performance review
2024 turnover reached EUR 5.413 billion, net result EUR 325 million, and EBITDA EUR 500 million, with a 9% margin on sales.
Revenue declined 18% year-on-year, EBITDA down 29%, but net profit only 1% lower due to prior asset impairments.
Share price closed the year down 11.3%, outperforming main European competitors.
Dividend of EUR 154.5 million distributed in 2024, up 3.3% from previous year, with a yield over 6%.
Board and executive committee updates
Board updated compliance, data protection, and tax policies, reinforcing transparency and accountability.
Directors' terms reduced from four to two years; executive committee renamed as strategic committee.
Over 40 board and committee meetings held during the year to address extraordinary challenges.
Latest events from Acerinox
- Net sales up 7%, adjusted EBITDA €422M, strong cash flow, Haynes integration, recovery ahead.ACX
Q4 202527 Feb 2026 - Q2 EBITDA of €125M and net debt reduction show resilience despite market and strike challenges.ACX
Q2 20243 Feb 2026 - Q3 EBITDA was €114 million; Bahru sale and Haynes deal to lift Q4 amid weak demand.ACX
Q3 202418 Jan 2026 - 2024 marked transformation with Haynes acquisition, Bahru sale, and resilient financials.ACX
Q4 202415 Dec 2025 - Q1 EBITDA reached €102M with strong cash flow and Q2 outlook improving.ACX
Q1 202519 Nov 2025 - Q2 EBITDA up 10% sequentially, but H1 profit fell on European weakness and tax impairment.ACX
Q2 202513 Nov 2025 - Q3 EBITDA €108M, cash flow strong, but demand weak; Q4 outlook cautious amid market headwinds.ACX
Q3 20253 Nov 2025